Sign Out
Lipway: Pregnancy: The results of animal studies have shown no evidence of teratogenic effect. In man, no malformations or foetotoxic effects have been observed to date. However, the experience of pregnancies exposed to fenofibrate is insufficient to rule out any risk. There is no indication of prescribing fibrates during pregnancy, with the exception of major hypertriglyceridaemia (>10 g/L) insufficiently corrected by diet, which exposes the mother to the risk of acute pancreatitis.
Lactation: In the absence of information on the possible excretion of fenofibrate in breast milk, use of the product during lactation is not recommended.
